A Phase I/II Study With CEA(6D) VRP Vaccine in Patients With Advanced or Metastatic CEA-Expressing Malignancies

Clinical trial NCT00529984 · COMPLETED

Trial details

NCT number: NCT00529984
Sponsor: AlphaVax, Inc.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Colorectal Cancer Breast Cancer Lung Cancer Pancreatic Cancer Colon Cancer

Start date: 2007-09-01
Primary completion: 2010-05-01
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.